THERAPEUTICS
Review: statins prevent stroke and reduce mortality
| The first 150 words of the full text of this article appear below. |
E J Mills
Dr E J Mills, McMaster University, Hamilton, Ontario, Canada; millsej@mcmaster.ca
QUESTION
In adults, do statins prevent stroke and reduce mortality?
REVIEW SCOPE
Included studies compared a statin (atorvastatin, fluvastatin, lovastatin, pravastatin, rosuvastatin, and simvastatin) with placebo or no treatment and reported on clinically important cardiovascular outcomes. Studies that reported only on surrogate outcomes (eg, low- and high-density lipoprotein levels) were excluded. Outcomes were all-cause mortality and all-stroke incidence. Secondary outcomes included cardiovascular deaths, non-haemorrhagic and haemorrhagic cerebrovascular events, and fatal strokes.
REVIEW METHODS
Medline, EMBASE/Excerpta Medica, Cochrane Central Register of Controlled Trials, Allied and Complementary Medicine Database, CINAHL, TOXNET, Development and Reproductive Toxicology, Hazardous Substances Databank, PsycINFO, and Web of Science (all from inception to December 2006), and references of published systematic reviews and health technology assessments were searched for randomised controlled trials (RCTs). 42 RCTs (n = 121 285) met the selection criteria: 8 used atorvastatin (n = 23 724), 6
Royal Perth Hospital, Perth, Western Australia, Australia
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
